Hansa Biopharma AB ( HNSBF) - Stock Earnings
HNSBF Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 11, 2026 AfterMarket | — / — | — | — / — | — |
HNSBF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -17.9 million USD | 8.3 million USD |
| 2026Q1 | -20.4 million USD | 3.6 million USD |
| 2026Q2 | -26.8 million USD | 5.0 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
HNSBF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -82.6 million USD | 13.3 million USD |
| 2024 | -73.3 million USD | 15.6 million USD |
| 2025 | -58.0 million USD | 24.1 million USD |
| 2026 Est. | — | — |
HNSBF
Price: $3.29
52 week price:
Earnings Per Share: -0.78 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 328.0 million